Compound ID | 1780

Update compound information

OMN6

Class: Antimicrobial peptide

Agent Type: Direct acting;
Spectrum of activity: Gram-negative
Mechanism of action: Membrane-active agent
Target Pathogen: Active against Acinetobacter
Description: Engineered 40-amino acid cyclic peptide based on cecropin A
Institute where first reported: Omnix
Year first mentioned: 2019
Highest development stage: Phase 2 (NCT06087536)
Development status: Active
External links:
Guide to Pharmacology: OMN6
Citations:
  • https://pubchem.ncbi.nlm.nih.gov/#query=OMN6
  • https://www.nature.com/articles/s41598-021-86155-9
  • https://omnixmedical.com/
    • Patent: US20190177379A1

    AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.